{"id":4196,"date":"2015-03-24T16:53:45","date_gmt":"2015-03-24T20:53:45","guid":{"rendered":"https:\/\/globalhealthintelligence.com\/?p=728"},"modified":"2025-12-01T13:23:49","modified_gmt":"2025-12-01T19:23:49","slug":"developing-new-devices-medtronics-top-priority-after-acquiring-covidien","status":"publish","type":"post","link":"https:\/\/globalhealthintelligence.com\/pt-br\/news\/developing-new-devices-medtronics-top-priority-after-acquiring-covidien\/","title":{"rendered":"Developing new devices: Medtronic\u2019s top priority after acquiring Covidien"},"content":{"rendered":"<p>The first and most important strategy of the combined company is to develop new devices by bringing together the technology platforms of both the companies, leading to reduction in device prices. Saving USD850 million over the next three years through cost cuts in operations, real estate, finance and human resources is also a part of the plan. The first year after integration will be focused on the elimination of redundancies, while the point of focus will be to sustain productivity changes for the following two years. Medtronic\u2019s market development and scale up expertise in combination with Covidien\u2019s experience to meet clinical needs with surgical tools and hospital services will ensure rapid growth and a dominant global presence for the combined company.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Medtronic has ambitious plans for growth after Covidien\u2019s acquisition. As a part of its growth strategy, the company\u2019s prime focus will be to develop new medical devices with an aim to support innovative therapies that would make healthcare more efficient with reduced costs. <\/p>\n","protected":false},"author":24,"featured_media":730,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[102],"tags":[],"class_list":{"0":"post-4196","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-news"},"_links":{"self":[{"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/posts\/4196","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/comments?post=4196"}],"version-history":[{"count":1,"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/posts\/4196\/revisions"}],"predecessor-version":[{"id":27744,"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/posts\/4196\/revisions\/27744"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/media?parent=4196"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/categories?post=4196"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/tags?post=4196"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}